In this article, we will take a look at the best US stocks to buy under $20.
Every investor is looking to invest in the ‘best’ stock, but that word means something different to each of us. The real differentiation comes when that stock also trades at a low price. Low-priced equities are often viewed with skepticism. But in today’s market, low-priced doesn’t necessarily mean low-quality. In fact, data suggest that many cheap stocks consistently receive “buy” and “strong buy” ratings from top Wall Street analysts.
While investors pile into stocks tied to the crowded AI trade, Wells Fargo’s Scott Wren, who appeared on CNBC on November 20, emphasised “the power of diversification.” According to Wren, the market is moving into sectors, such as financials, industrials, and utilities, as he believes that this shift is a “cheaper way to get some exposure” to AI than directly investing in the tech sector. He adds that the diversification shouldn’t be too far away from the companies that are really growing. His comments suggest that attractive value can be found outside the market’s most popular themes.
With this diversification in mind, we have compiled a list of the best U.S. under $20 stocks to buy now. These stocks represent firms across various industries, including healthcare, defence, and communication services.
Photo by Annie Spratt on Unsplash
Our methodology
Our list of the best U.S. stocks priced under $20 is based on selecting leading companies with strong potential. We began by filtering for U.S. stocks having a market capitalisation of more than $2 billion and trading under $20. From this pool, we selected companies with an upside potential of over 20%. We then shortlisted the top 10 companies with the highest upside potential and ranked them in ascending order. We also included data on hedge fund holdings in these companies based on Insider Monkey’s database, as of Q3 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
10. CleanSpark, Inc. (NASDAQ:CLSK)
Upside Potential as of November 26, 2025: 82.16%
Number of Hedge Fund Holders: 34
Share Price as of November 26, 2025: $13.45
On November 25, CleanSpark, Inc. (NASDAQ:CLSK) reported its third-quarter results, in which it delivered revenue of $766.3 million, an impressive 102% increase from last year. Additionally, the company achieved a net income of $364.5 million, a strong rebound from the previous year’s net loss. Looking ahead, the company will focus on developing AI data center capabilities while winning new tenants for sites in Sandersville, Georgia, and Texas.
Entering 2026, management anticipates an EPS of $0.18 in Q1 2026 and $0.23 in Q2 2026, with annual guidance of $0.91 for 2026. To support the accelerating growth, CleanSpark, Inc. (NASDAQ:CLSK) will expand its power and land offerings.
With an emphasis on AI, CleanSpark, Inc. (NASDAQ:CLSK) is uniquely positioned in its market. As stated by CFO Gary Vecchiarelli,
“We are one of the first, if not the only company, which has a scaled cash-flowing business that is also using Bitcoin as a productive capital asset.”
According to TheFly, JPMorgan upgraded CleanSpark, Inc. (NASDAQ:CLSK) to Overweight from Neutral, with an unchanged $14 price target on November 24, right before the company’s third-quarter results. The firm highlighted the company’s latest share pullback while praising it for 200 MW of “critical IT capacity” at the 285 MW facility it recently acquired in Texas. What’s even more interesting is that the “flurry of deal activity” in high-performance computing is strengthening JPMorgan’s confidence in the bitcoin miners.
CleanSpark, Inc. (NASDAQ:CLSK) is a Nevada-based bitcoin mining company specializing in data centers. Incorporated in 1987, the company’s infrastructure supports Bitcoin.
9. Fermi Inc. (NASDAQ:FRMI)
Upside Potential as of November 26, 2025: 102.40%
Number of Hedge Fund Holders: NA
Share Price as of November 26, 2025: $15.81
As of November 26, Fermi Inc. (NASDAQ:FRMI) is a consensus Buy with all the analysts covering it assigning a Buy or equivalent rating. With a consensus 1-year median price target of $32, the stock has an upside of over 102%.
On November 12, Cantor Fitzgerald reaffirmed an ‘Overweight’ rating on Fermi Inc. (NASDAQ:FRMI), with an unchanged price target of $33. This potential upside of about 108% is attributed to the company’s huge data center development in Texas.
The company’s 5,200-acre campus in Amarillo, Texas, is poised to become the largest artificial intelligence data center campus in the United States if executed well, the firm highlighted. By 2038, this site is anticipated to deliver 11 GW of tenant-direct power, along with nearly 15 million square feet of data center shells, Cantor Fitzgerald added.
What’s even more interesting is that Fermi Inc. (NASDAQ:FRMI) is well-positioned to achieve approximately 1.1 GW in new power by the end of 2026, which the research firm believes is unmatched.
On the same day, Nicholas Amicucci, an analyst at Evercore ISI, reiterated the ‘Buy’ rating on Fermi Inc. (NASDAQ:FRMI), while keeping a price target of $37. This price target implies a potential surge of about 134% from the current price level.
Fermi Inc. (NASDAQ:FRMI) is a Texas-based energy and hyperscaler development company specializing in infrastructure for the development of AI. Founded in January 2025, the company is focused on “powering the AI needs of tomorrow.”
8. Quantum Computing Inc. (NASDAQ:QUBT)
Upside Potential as of November 26, 2025: 109.42%
Number of Hedge Fund Holders: 17
Share Price as of November 26, 2025: $11.46
On November 17, Max Michaelis, an analyst at Lake Street, reaffirmed the ‘Buy’ rating on Quantum Computing Inc. (NASDAQ:QUBT), while slashing the price target to $16 from $24, which suggests an upside potential of about 38%. Although the analyst thinks the stock could surge higher given investors’ clearer view of the company’s revenue revamp and considering the opportunities in this greenfield sector, the lower price target reflects the “broader multiple compression” in quantum computing, according to TheFly.
During its earnings call on November 14, management unveiled a three-year plan to improve the manufacturing process and enhance production. Quantum Computing Inc. (NASDAQ:QUBT) is committed to accelerating technology development through mergers and acquisitions, together with transitioning to volume production by the end of the decade. Dr. Yuping Huang, the CEO, noted the company’s dedication to making quantum technology accessible. As he cites,
“We are working to make quantum usable for a broader community of industries and innovators.”
Investors eye the company’s participation in the UBS Global Technology and AI Conference, announced on November 25. Scheduled for December 1-4 in Scottsdale, Arizona, the conference will feature Dr. Yuping Huang, Interim Chief Executive Officer, and Chris Roberts, Chief Financial Officer.
Quantum Computing Inc. (NASDAQ:QUBT) is a New Jersey-based integrated photonics company specializing in quantum machines for both commercial and government markets. Founded in 2001, the company is also engaged in the development of entropy quantum computers.
7. Bath & Body Works, Inc. (NYSE:BBWI)
Upside Potential as of November 26, 2025: 118.77%
Number of Hedge Fund Holders: 49
Share Price as of November 26, 2025: $17.37
On November 21, Jefferies analyst trimmed the price target on Bath & Body Works, Inc. (NYSE:BBWI) to $16.00 from $28.50, while maintaining an ‘Hold’ rating on the stock. The firm highlighted the company’s recent third-quarter sales and EPS that underperformed estimates. Not only that, management revised the company’s full-year guidance downward.
Jefferies warned that sustained macroeconomic headwinds continue to impact sales, prompting the postponement of initiatives to support the business. This means Bath & Body Works, Inc. (NYSE:BBWI) will witness only limited growth above forecasts for now, the analyst added.
On the same day, UBS also reduced its price target on Bath & Body Works, Inc. (NYSE:BBWI) to $17.00 from $32.00, while keeping its rating ‘Neutral.’ This pessimism comes right after the company announced its earnings on November 20, which the firm says reported trends “much worse than previously thought.” UBS further notes that the company is currently entering a “multiyear process” of business recovery.
With this view in mind, UBS lowered its fiscal year 2025-27 estimates by nearly 29-30%, expecting a -1% five-year EPS compound annual growth rate for Bath & Body Works, Inc. (NYSE:BBWI), a considerable dip from its previous +6% estimate.
Bath & Body Works, Inc. (NYSE:BBWI) is an Ohio-based specialty retailer of products, such as home fragrance, personal and body care, and soaps. Founded in 1963, the company operates under various names like Bath & Body Works and White Barn.
6. Primo Brands Corporation (NYSE:PRMB)
Upside Potential as of November 26, 2025: 123.93%
Number of Hedge Fund Holders: 62
Share Price as of November 26, 2025: $15.63
On November 25, Bonnie Herzog, an analyst at Goldman Sachs, trimmed the price target on Primo Brands Corporation (NYSE:PRMB) to $18 from $21, while maintaining a Neutral stance on the stock, according to TheFly. In a research note, the analyst raised concerns regarding the sales decline, which she believes will be faster and more prolonged than anticipated. With respect to that, the firm expects incremental headwinds for the company in the times ahead.
Herzog names the company’s direct delivery business, which contributes heavily to the sales, as the one facing service disruptions. This, in turn, fuels worries about the company’s near-term ability to rebound. Additionally, a blurred visibility into the recovery timeline and the risk of further strain on the direct-delivery segment contribute to the overall cautious outlook.
Recently, many other analysts have covered Primo Brands Corporation (NYSE:PRMB). On November 19, Truist Financial analyst Bill Chappell reaffirmed the ‘Buy’ rating on the stock. Earlier on November 7, BMO Capital slashed the price target on PRMB to $39.00 from $42.00, with an unchanged ‘Outperform’ rating. The analyst cited the company’s third-quarter results, in which retail performance exceeded expectations.
Primo Brands Corporation (NYSE:PRMB) is a Connecticut-based branded beverage company. Incorporated in 1976, the company provides healthy hydration options across North America.
5. StubHub Holdings, Inc. (NYSE:STUB)
Upside Potential as of November 26, 2025: 126.10%
Number of Hedge Fund Holders: 29
Share Price as of November 26, 2025: $15.48
As of November 26, StubHub Holdings, Inc. (NYSE:STUB) is a strong Buy, with around two-thirds of analysts covering it assigning a Buy or equivalent rating. With a consensus 1-year median price target of $25, the stock has an upside of over 126%.
According to TheFly, BofA downgraded StubHub Holdings, Inc. (NYSE:STUB) to Neutral from Buy on November 14, with a reduced price target of $19 from $25. The revised price target, which suggests a potential upside of nearly 60%, closely follows the company’s third-quarter results.
Despite third-quarter revenue and EBITDA surpassing Street estimates, StubHub Holdings, Inc. (NYSE:STUB) didn’t provide any guidance for the next quarter, with the earnings call suggesting limited visibility into 2026 tour timing, the analyst noted. Consequently, BofA lowered its estimates for the company’s fourth quarter and 2026, anticipating a more cautious outlook for 2026.
Earlier on November 13, StubHub Holdings, Inc. (NYSE:STUB) announced its third-quarter results, with revenue surging 8% year over year to $468 million. The company also delivered a 21% rise in adjusted EBITDA, reaching $67 million. For the quarters ahead, management revealed plans to accelerate direct issuance capabilities, while anticipating significant opportunities from upcoming events, including the World Cup.
StubHub Holdings, Inc. (NYSE:STUB) is a New York-based ticketing platform for live event tickets. Founded in 2000, the company buys and sells a diverse range of event tickets through its website and mobile application.
4. MARA Holdings, Inc. (NASDAQ:MARA)
Upside Potential as of November 26, 2025: 134.02%
Number of Hedge Fund Holders: 35
Share Price as of November 26, 2025: $11.11
As of November 26, MARA Holdings, Inc. (NASDAQ:MARA) faces mixed analyst opinions, with slightly more than half of all the analysts covering it assigning a Buy or equivalent rating. With a consensus 1-year median price target of $26, the stock has an upside of over 134%.
On November 24, JPMorgan reaffirmed its Overweight rating on the stock but reduced the price target from $20 to $13. The firm lowered its estimates due to a decline in bitcoin prices and a decrease in share count, leading to a downward revision of the price target.
Earlier, on November 5, 2025, Clear Street reduced the price target on MARA Holdings, Inc. (NASDAQ:MARA) to $16 from $18, while keeping a ‘Hold’ rating on the stock, as reported by TheFly. Not only that, the firm has trimmed its 2025-27 revenue guidance by nearly 13% and adjusted EBITDA by approximately 25%. Although the company’s transition from an asset-light miner to a vertically integrated operator is a “sound” strategy, MARA is about a year behind its peers in execution, according to Clear Street.
On the same day, Cantor Fitzgerald also trimmed its price target on MARA Holdings, Inc. (NASDAQ:MARA) to $21.00 from $30.00, with an ‘Overweight’ rating. This downward revision in outlook reflected “the recent move lower in Bitcoin,” the analyst said. Overall, the investment bank highlighted the company’s business strategy, stating that it is “extremely focused on diversifying its business.” With this adopted approach, the firm believes, if successful, “MARA’s business could be significantly bigger.”
Both of these ratings followed closely on the heels of MARA Holdings, Inc. (NASDAQ:MARA) announcing its third-quarter results on November 4, reporting a 370% positive surprise in EPS. The actual revenue was also slightly ahead of expectations.
MARA Holdings, Inc. (NASDAQ:MARA) is a Florida-based digital asset technology company with a presence across the United States and Europe. Founded in 2010, the company also specializes in technology solutions to enhance data center operations.
3. The GEO Group, Inc. (NYSE:GEO)
Upside Potential as of November 26, 2025: 137.48%
Number of Hedge Fund Holders: 47
Share Price as of November 26, 2025: $15.58
As of November 26, The GEO Group, Inc. (NYSE:GEO) is a consensus Buy with all analysts covering it assigning a Buy or equivalent rating. With a consensus 1-year median price target of $37, the stock has an upside of over 137%.
On November 10, Joe Gomes, an analyst at Noble Financial, reaffirmed the ‘Buy’ rating on The GEO Group, Inc. (NYSE:GEO), with a price target of $35, which suggests an upside potential of over 120%.
Separately, Jones Trading trimmed its price target on The GEO Group, Inc. (NYSE:GEO)to $37.00 from $50.00, while maintaining a ‘Buy’ rating on the stock on November 7. Both these ratings closely follow the company’s third-quarter financial report.
Earlier on November 6, The GEO Group, Inc. (NYSE:GEO) delivered its third-quarter results, outperforming market consensus by reporting EPS of $0.25, compared with the forecasted $0.23. Similarly, the company’s revenue also surpassed expectations, reaching $682.3 million, compared to an estimated $664.39 million.
During the earnings call, Mark Suchinski, the CFO, expressed his confidence in the company’s growth trajectory by believing that the “stock price is significantly undervalued.” Entering the next quarter, The GEO Group, Inc. (NYSE:GEO) has won some new deals. As stated by the CEO, George Zoley,
“We’ve entered into new contracts that represent over $460 million in new incremental annualized revenues.”
The GEO Group, Inc. (NYSE:GEO) is a Florida-based diversified government service provider. The company’s core offerings include in-custody rehabilitation and post-release support, as well as electronic monitoring, community-based programs, and correctional health and mental health care.
2. Firefly Aerospace Inc. (NASDAQ:FLY)
Upside Potential as of November 26, 2025: 206.94%
Number of Hedge Fund Holders: 22
Share Price as of November 26, 2025: $17.43
On November 20, 2025, Anthony Valentini, an analyst at Goldman Sachs, reinstated coverage on Firefly Aerospace Inc. (NASDAQ:FLY) with a ‘Neutral’ rating and price target of $29, according to TheFly.
This potential upside of nearly 67% is associated with the nascent space market that the company is serving. The analyst highlights in a research note that this market segment is poised to accelerate in the years ahead as it fills the gap in a supply-constrained space launch domain. While Firefly Aerospace Inc. (NASDAQ:FLY) is in a good medium- to long-term position, the launch industry risk and the company’s recent launch mishaps raise concerns, Goldman adds.
Three days earlier, on November 17, Morgan Stanley trimmed its price target on Firefly Aerospace Inc. (NASDAQ:FLY), with an unchanged “Equalweight” rating on the stock. The leading financial services firm compares the company’s inconsistent results of mere six launches to date with Rocket Lab’s solid record of 74 launches with 70 successes, advocating for a greater concession for Firefly Aerospace until it “reestablishes its footing with Alpha.”
Firefly Aerospace Inc. (NASDAQ:FLY) is a Texas-based space and defense technology company specializing in mission solutions for government and commercial customers. Founded in 2017, the company provides launch vehicles under the Alpha, Eclipse, Blue Ghost, Elytra, and Ocula brands.
1. ImmunityBio, Inc. (NASDAQ:IBRX)
Upside Potential as of November 26, 2025: 275.59%
Number of Hedge Fund Holders: 18
Share Price as of November 26, 2025: $2.13
As of November 26, ImmunityBio Inc. (NASDAQ:IBRX) is a consensus Buy, with all analysts covering it assigning a Buy or equivalent rating. With a consensus 1-year median price target of $8, the stock has an upside of over 275%.
On November 13, Jason Kolbert, an analyst at D. Boral Capital, reaffirmed his ‘Buy’ rating on ImmunityBio, Inc. (NASDAQ:IBRX), with an unchanged price target of $24. This stance is in line with the analyst’s previous rating on November 5, 2025.
During the recent quarter, ImmunityBio, Inc. (NASDAQ:IBRX) reported a substantial increase in revenue, thanks to the commercial distribution of ANKTIV A, its lead product targeting non-muscle-invasive bladder cancer. With total revenue of $75 million for the nine months ended September 30, the company impressively surpassed the $7.2 million level in the same period in 2024.
Although revenue growth stole the spotlight, ImmunityBio, Inc. (NASDAQ:IBRX) found itself in the middle of financial challenges, having reported a net loss of $289.5 million for the nine-month period. Much of this loss is due to the company’s operating expenses, primarily R&D outflows. Throughout the earnings call, management highlighted its focus on ANKTIV A’s market expansion and development of immunotherapy and cell therapy products.
ImmunityBio, Inc. (NASDAQ:IBRX) is a California-based commercial-stage biotechnology company that engages in therapies to combat cancers and infectious diseases. With a mission to “conquer cancer,” the company leverages its collaborations with the National Cancer Institute, Serum Institute of India Private Limited, and BeiGene, Ltd.
While we acknowledge the potential of IBRX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IBRX and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
